AMOEBA (EPA:ALMIB) | Finanzwire

BRIEF

published on 10/29/2025 at 08:05, 3 months 1 day ago

Amoéba: Positive Results of the 2025 Vine Trials

AXPERA Copper Reduction Viticultural Trials Mildew Commercialization 2026
PRESS RELEASE

published on 10/29/2025 at 08:00, 3 months 1 day ago

Amoéba presents the 2025 results of its vineyard trial campaign: AXPERA confirms its effectiveness against downy mildew and its strong potential to significantly reduce copper use
Amoéba presents 2025 vineyard trial results confirming AXPERA's efficacy against downy mildew. AXPERA's performance in real conditions and response to French regulatory framework highlighted. Market authorization process and commercial launch details shared

AMOEBA Regulatory Framework Market Authorization AXPERA Vineyard Trial
BRIEF

published on 10/24/2025 at 18:05, 3 months 5 days ago

Amoéba Publishes its Half-Yearly Financial Report

AMOEBA Financial Report Biocontrol Cosmetic Patented Amoebas
PRESS RELEASE

published on 10/24/2025 at 18:00, 3 months 5 days ago

Amoéba: Publication of the half-year financial report as of June 30, 2025
Amoéba announces the availability of its half-year financial report for the period ending June 30, 2025, filed with the French Financial Markets Authority. The report can be accessed on the company's website

AMOEBA French Financial Markets Authority Half-year Financial Report GreenTech Microbiological Solutions
BRIEF

published on 10/20/2025 at 18:35, 3 months 9 days ago

AXPERA awarded for its innovation in biocontrol

AMOEBA Innovation Biocontrol Environment AXPERA
PRESS RELEASE

published on 10/20/2025 at 18:30, 3 months 9 days ago

AXPERA named biocontrol solution of the year 2025 // Amoeba's anti-fungal innovation wins the Gold Award at the 2025 Bernard Blum Awards
Amoéba wins prestigious Bernard Blum Gold Medal for innovation in biocontrol with AXPERA, a natural microbiological solution based on amoebae, offering plant protection against fungal diseases. Award highlights Amoéba's excellence in sustainable agriculture

AMOEBA Sustainable Agriculture Biocontrol AXPERA Bernard Blum Gold Medal
BRIEF

published on 10/16/2025 at 18:05, 3 months 13 days ago

AMOÉBA obtains US EPA authorization for AXPERA in the United States

Partnership American Market Agriculture Biocontrol AXPERA
PRESS RELEASE

published on 10/16/2025 at 18:00, 3 months 13 days ago

Amoéba obtains market authorisation in the United States for its AXPERA biocontrol solution
Amoéba's biocontrol fungicides AXPERA NOA and AXPERA GREEN receive US EPA approval for speciality crops. Strategic market expansion in Europe and the US in 2026

AMOEBA Market Expansion US EPA Approval Biocontrol Fungicides Speciality Crops
BRIEF

published on 10/15/2025 at 18:05, 3 months 14 days ago

Appointment of Jean-Marc PETAT as head of Green 4 Agro

AMOEBA Biocontrol AXPERA Green 4 Agro Jean-Marc PETAT
PRESS RELEASE

published on 10/15/2025 at 18:00, 3 months 14 days ago

Amoéba announces the appointment of Jean-Marc PETAT as Managing Director of Green 4 Agro, its dedicated subsidiary for biocontrol and biostimulants in agriculture
Amoéba appoints Jean-Marc PETAT as Managing Director of Green 4 Agro, its subsidiary dedicated to biocontrol and biostimulant solutions, strengthening its position in the agroecological transition

AMOEBA Biocontrol Green 4 Agro Jean-Marc PETAT Agroecological Transition

Published on 01/30/2026 at 08:35, 3 hours 7 minutes ago

Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 08:00, 3 hours 42 minutes ago

Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 9 hours 27 minutes ago

Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 11 hours 42 minutes ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/29/2026 at 23:00, 12 hours 42 minutes ago

PPX Mining Announces Filing of 2025 Audited Financial Statements and MD&A

View all ACCESSWIRE

Published on 01/30/2026 at 10:30, 1 hour 11 minutes ago

ASTA ENERGY SOLUTIONS AG SUCCESSFULLY COMPLETES IPO
Published on 01/30/2026 at 10:00, 1 hour 42 minutes ago

Appointment of Managing Director of Tradegate BSX
Published on 01/30/2026 at 09:00, 2 hours 41 minutes ago

Original-Research: 123fahrschule SE (von NuWays AG): BUY
Published on 01/30/2026 at 09:00, 2 hours 41 minutes ago

Original-Research: q.beyond AG (von NuWays AG): BUY
Published on 01/30/2026 at 09:00, 2 hours 41 minutes ago

Official List Notice

View all EQS

Published on 01/30/2026 at 08:00, 3 hours 42 minutes ago

AMA: 4th Quarter & FY 2025 Revenues
Published on 01/29/2026 at 18:00, 17 hours 42 minutes ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 17 hours 57 minutes ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 17 hours 57 minutes ago

Cegedim generated LFL revenue growth of 1.1% in 2025
Published on 01/29/2026 at 17:40, 18 hours 2 minutes ago

ALTEN: Annual revenue 2025

View all LES ECHOS COMFI WIRE

News